2m 2m 2m 2m 2m 2m 2m
ProUroCare Med (PUMD)
OTC
$0.0001$0.00 (0.00%)
Price as of May 21, 2026- N/AMarket Cap
- 0.00%1-Year Change
- Medical DevicesIndustry
ProUroCare Med (PUMD)
$0.0001$0.00 (0.00%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$0.0001
$0.0001
$0.0001
1-Year Range
$0.0001
$0.0002
$0.0001
Latest Close$0.0001
Change
$0.00 (0.00%)
Volume20,000
Information as of 05/21/2026
Company Profile
ProUroCare Medical Inc.
https://www.prourocare.comN/A
Market Cap
N/A
Net Income
Sector: Healthcare
Industry: Medical Devices
6440 Flying Cloud Drive, Eden Prairie, MN, United States, 55416
952-476-9093ProUroCare Medical Inc. engages in developing products for the detection and characterization of male urological prostate disease. It offers the ProUroScan System, a prostate imaging system that aids the physician in documenting abnormalities in the prostate that have been previously detected by a digital rectal exam. The company has licensing, development, and commercialization agreements with Artann Laboratories Inc. for its ProUroScan System. ProUroCare Medical Inc. was founded in 1999 and is based in Eden Prairie, Minnesota.
Key Executives
- Alan G. Shuler
- Benjamin Banks
Current Ownership Distribution
- Other18.4M (99.10%)
- Insiders167,605 (0.90%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)